Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)

Research Site, Brasschaat

Research Site, Liège

Research Site, Overpelt

Research Site, Wilrijk

Research Site, Amiens

Research Site, Besançon

Research Site, Bron

Research Site, Lille

Research Site, Montpellier

Research Site, Nantes

Research Site, Nice

Research Site, Paris

Research Site, Rennes

Research Site, Strasbourg

Research Site, Toulouse

Research Site, Andernach

Research Site, Bamberg

Research Site, Berlin

Research Site, Bochum

Research Site, Bonn

Research Site, Dresden

Research Site, Emmendingen

Research Site, Erbach im Odenwald

Research Site, Erlangen

Research Site, Frankfurt

Research Site, Freiburg im Breisgau

Research Site, Heidelberg

Research Site, Jena

Research Site, Mainz

Research Site, Marburg

Research Site, München

Research Site, Neuburg am Inn

Research Site, Regensburg

Research Site, Tübingen

Research Site, Ulm

Research Site, Wermsdorf

Research Site, Bari

Research Site, Catania

Research Site, Cefalù

Research Site, Chieti

Research Site, Florence

Research Site, Gallarate

Research Site, L’Aquila

Research Site, Milan

Research Site, Montichiari

Research Site, Napoli

Research Site, Orbassano

Research Site, Padua

Research Site, Palermo

Research Site, Pavia

Research Site, Pozzilli

Research Site, Roma

Research Site, Sassari

Research Site, Torino

Research Site, Barcelona

Research Site, Donostia / San Sebastian

Research Site, Girona

Research Site, Lleida

Research Site, Málaga

Research Site, Murcia

Research Site, Oviedo

Research Site, Pamplona

Research Site, Santa Cruz de Tenerife

Research Site, Seville